semaglutide and gastric emptying Liraglutide, semaglutide, tirzepatide delay and Peptides semaglutide: what this GLP-1

Injectable GLP-1 medications are delivered by a very small needle into the top fatty layer just beneath the skin

Of particular concern are new findings linking semaglutide-based medications, including Ozempic, Wegovy, and Rybelsus, to a rare but devastating eye condition

Myth: You have to start at the lowest Wegovy dose Reality: While the licensed starting dose is 0.25 mg, prescribers commonly start patients switching from Mounjaro at higher doses based on their current dose and tolerance

When patients understand both the metabolic benefits and the potential hepatobiliary risks, they are more likely to engage in proactive symptom reporting

Clinicians should actively listen to their patients concerns